Our memberships, custom support, and in-depth published research equip you with the reliable information you need to make data-led decisions with measurable success.
We’re committed to helping you get it right. Through trusted expertise, rigorous research, and practical insights, we enable businesses to make confident decisions.
Our memberships, custom support, and in-depth published research equip you with the reliable information you need to make data-led decisions with measurable success.
We’re committed to helping you get it right. Through trusted expertise, rigorous research, and practical insights, we enable businesses to make confident decisions.
Life sciences enterprises are embracing digital technologies to navigate the growing complexities in drug development, commercialization, and regulatory compliance. As economic pressures and competitive dynamics intensify, organizations are turning to digital services to improve operational resilience…
The increasing adoption of AI, generative AI, analytics, and industry-specific solutions across drug development, commercialization, and regulatory compliance is driving the rapid growth of digital services in the life sciences sector. Enterprises are turning to these…
The pandemic necessitated and accelerated the rapid adoption of digital services across the Life Sciences (LS) value chain. Therefore, there has been a conscious shift in enterprise mindset to focus on delivering products and services in…
The pandemic necessitated and accelerated the rapid adoption of digital services across the Life Sciences (LS) value chain. As a result, there has been a shift in enterprise mindset to become more customer-centric and invest in…
The Life Sciences (LS) industry has been at the forefront of the COVID-19 response, ranging from carrying out drug trials and vaccine development to producing Personal Protective Equipment (PPE) and ventilators. There has also been a…
The Life Sciences (LS) industry has been at the forefront of the COVID-19 response, from carrying out drug trials and vaccine development to producing Personal Protective Equipment (PPE) and ventilators. The industry was already growing significantly…
The life sciences industry is plagued by issues such as high time-to-market for drugs and high costs of drug development. Enterprises have prioritized digital technologies in their corporate strategies to optimize processes, reduce costs, and positively…
The Industry Trends reports provide industry-specific data, developments, and insights that enable global sourcing managers to navigate through the complexity and make clear and effective decisions suited to their specific industries. These reports provide detailed information…
The Life Sciences (LS) industry is now beginning to look at digital transformation more seriously. The European LS market has a number of distinctive characteristics, including price regulations, need for General Data Protection Regulation (GDPR) and…
The Life Sciences (LS) industry is now beginning to look at digital transformation seriously. With the advent of omni-channel information through IoT devices, mobility, and social media, consumers are gaining access to innovative ways of managing…
The United States healthcare market experienced a tectonic shift in 2017, with President Trump’s (thus far unsuccessful) pursuit to repeal the Affordable Care Act (ACA) and replace it with a new law. Given the uncertainty of…
The Healthcare and Life Sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with…
Introduction The healthcare landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with mobile computing, social…
The Healthcare and Life Sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with…
Introduction The Healthcare and Life Sciences (HLS) industry has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm…
The Healthcare and Life Sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with…
Introduction The healthcare landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with mobile computing, social…
Introduction The healthcare landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with mobile computing, social…
Introduction The healthcare and life sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm…